AJP - Heart Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (June 8, 2007). doi:10.1152/ajpheart.00159.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/3/H1662    most recent
00159.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ulucan, C.
Right arrow Articles by Ishikawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ulucan, C.
Right arrow Articles by Ishikawa, Y.
Submitted on February 7, 2007
Accepted on June 4, 2007

Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy

Coskun Ulucan1, Xu Wang2, Erdene Baljinnyam2, Yun Zhe Bai3, Satoshi Okumura3, Motohiko Sato3, Susumu Minamisawa3, Shinichi Hirotani4, and Yoshihiro Ishikawa5*

1 Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan; Cardiovascular Research Institute, Departments of Cell Biology & Molecular Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States
2 Cardiovascular Research Institute, Departments of Cell Biology & Molecular Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States
3 Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan
4 Departments of Cell Biology & Molecular Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States
5 Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Yokohama, Japan; Cardiovascular Research Institute, Departments of Cell Biology & Molecular Medicine, UMDNJ-New Jersey Medical School, Newark, New Jersey, United States; Department of Medicine (Cardiology), UMDNJ-New Jersey Medical School, Newark, New Jersey, United States

* To whom correspondence should be addressed. E-mail: ishikayo{at}umdnj.edu.

Although it has been shown that Epac1 mRNA is expressed ubiquitously and Epac2 mRNA predominantly in the brain and endocrine tissues, developmental and pathophysiological changes of these molecules have not been characterized. Developmental changes were analysed in murine heart, brain, kidneys and lungs by RT-PCR analysis, which revealed more drastic developmental changes of Epac2 mRNA than of Epac1. Only the Epac2 mRNA in kidney showed a transient expression pattern with dramatic decline into adulthood. In addition to developmental changes, we found that Epac gene expression was upregulated in myocardial hypertrophy induced by chronic isoproterenol infusion or pressure-overload by transverse aortic banding. Both Epac1 and Epac2 mRNA were upregulated in isoproterenol-induced left ventricular hypertrophy, whereas only Epac1 was increased in pressure-overload-induced hypertrophy. Stimulation of H9c2, cardiac myoblast cells, with fetal calf serum, which can induce myocyte hypertrophy, upregulated Epac1 protein expression. We also demonstrated that Epac was the limiting moiety, relative to Rap, in the Epac-Rap signaling pathway in terms of stoichiometry, and that Epac stimulation led to the activation of ERK1/2. Our data suggest the functional involvement of Epac in organogenesis and also in physiological as well as pathophysiological processes, such as cardiac hypertrophy. Furthermore our results suggest the importance of the stoichiometry of Epac over that of Rap in cellular biological effects.




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Baljinnyam, K. Iwatsubo, R. Kurotani, X. Wang, C. Ulucan, M. Iwatsubo, D. Lagunoff, and Y. Ishikawa
Epac increases melanoma cell migration by a heparan sulfate-related mechanism
Am J Physiol Cell Physiol, October 1, 2009; 297(4): C802 - C813.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
P. Cao, J.-i. Hanai, P. Tanksale, S. Imamura, V. P. Sukhatme, and S. H. Lecker
Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect
FASEB J, September 1, 2009; 23(9): 2844 - 2854.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Cazorla, A. Lucas, F. Poirier, A. Lacampagne, and F. Lezoualc'h
The cAMP binding protein Epac regulates cardiac myofilament function
PNAS, August 18, 2009; 106(33): 14144 - 14149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
U. Yokoyama, S. Minamisawa, H. Quan, T. Akaike, M. Jin, K. Otsu, C. Ulucan, X. Wang, E. Baljinnyam, M. Takaoka, et al.
Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1547 - H1555.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Metrich, A. Lucas, M. Gastineau, J.-L. Samuel, C. Heymes, E. Morel, and F. Lezoualc'h
Epac Mediates {beta}-Adrenergic Receptor-Induced Cardiomyocyte Hypertrophy
Circ. Res., April 25, 2008; 102(8): 959 - 965.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.